8-K/A - Tarsus Pharmaceuticals, Inc. (0001819790) (Filer)
Published . Updated .
Filed: 2026-10-13 AccNo: 0001819790-26-000069 Size: 12 MB Item 9.01: Financial Statements and Exhibits
Directly affected
- TARS Tarsus Pharmaceuticals
Named in this report.
Indirectly affected
- XPH STATE STREET SPDR S&P PHARMACEUTICALS ETF
GA selected XPH as a RELATED security because its canonical security name directly matches this event's themes: pharmaceuticals. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
Filed: 2026-10-13 AccNo: 0001819790-26-000069 Size: 12 MB Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Tarsus Pharmaceuticals (TARS)
| Company | When | Average | Largest gain | Largest drop | Prices |
|---|---|---|---|---|---|
| State Street Spdr S&P Pharmaceuticals Etf (XPH) | the next day | -0.91% | +0.60% | -3.94% | 3 |
| State Street Spdr S&P Pharmaceuticals Etf (XPH) | three days later | -2.47% | -2.45% | -2.52% | 3 |
Tarsus Pharmaceuticals (TARS) since this story, compared with the market
Since the first closing price after “8-K/A - Tarsus Pharmaceuticals, Inc. (0001819790) (Filer),” Tarsus Pharmaceuticals (TARS) is -3.99%. The S&P 500 fund (SPY) is -0.40% over the same days, a -3.59% difference versus the market.
| Company | When | Move | Status |
|---|---|---|---|
| GLD | that day | -1.49% | final price |
| GLD | the next day | +0.27% | final price |
| GLD | two days later | +0.10% | final price |
| GLD | three days later | -0.52% | final price |
| GLD | three days earlier | +0.77% | final price |
| GLD | five days earlier | -1.52% | final price |
| QQQ | that day | -1.97% | final price |
| QQQ | the next day | -2.08% | final price |
| QQQ | two days later | -4.55% | final price |
| QQQ | three days later | -3.41% | final price |
| QQQ | three days earlier | +1.02% | final price |
| QQQ | five days earlier | +1.90% | final price |
| SPY | that day | -1.08% | final price |
| SPY | the next day | -0.80% | final price |
| SPY | two days later | -1.89% | final price |
| SPY | three days later | -1.47% | final price |
| SPY | three days earlier | +0.06% | final price |
| SPY | five days earlier | -0.11% | final price |
| Tarsus Pharmaceuticals (TARS) | that day | +2.08% | final price |
| Tarsus Pharmaceuticals (TARS) | the next day | +0.24% | final price |
| Tarsus Pharmaceuticals (TARS) | two days later | -3.88% | final price |
| Tarsus Pharmaceuticals (TARS) | three days later | -1.86% | final price |
| Tarsus Pharmaceuticals (TARS) | three days earlier | +3.30% | final price |
| Tarsus Pharmaceuticals (TARS) | five days earlier | +3.94% | final price |
| TLT | that day | +0.68% | final price |
| TLT | the next day | +2.09% | final price |
| TLT | two days later | +2.15% | final price |
| TLT | three days later | +1.42% | final price |
| TLT | three days earlier | -0.50% | final price |
| TLT | five days earlier | -1.52% | final price |
Who gains and who loses around Tarsus Pharmaceuticals (TARS)
Companies tied to this story
- TARS Tarsus Pharmaceuticals
Tarsus Pharmaceuticals (TARS) is linked, with no stored direction, high confidence in the 13 Oct 2026 story “8-K/A - Tarsus Pharmaceuticals, Inc. (0001819790) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> TARS
- XPH State Street Spdr S&P Pharmaceuticals Etf
For “8-K/A - Tarsus Pharmaceuticals, Inc. (0001819790) (Filer),” State Street Spdr S&P Pharmaceuticals Etf (XPH) is linked, with no stored direction, medium confidence. Reason on file: GA selected XPH as a RELATED security because its canonical security name directly matches this event's themes: pharmaceuticals. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
How “8-K/A - Tarsus Pharmaceuticals, Inc. (0001819790) (Filer)” reaches Tarsus Pharmaceuticals (TARS)
The 13 Oct 2026 story “8-K/A - Tarsus Pharmaceuticals, Inc. (0001819790) (Filer)” names Tarsus Pharmaceuticals (TARS) because of this story.
For Tarsus Pharmaceuticals (TARS), the reason on file says SEC 8-K filing -> direct issuer disclosure -> TARS
State Street Spdr S&P Pharmaceuticals Etf (XPH) is here too. Its reason reads: GA selected XPH as a RELATED security because its canonical security name directly matches this event's themes: pharmaceuticals. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
The price range for Tarsus Pharmaceuticals (TARS), and the dates in the story
TARS traded between 68.08 and 80.09 across 7 sessions. The latest close on file is 69.44. XPH traded between 61.54 and 68.95 across 20 sessions. The latest close on file is 62.24.
How solid “8-K/A - Tarsus Pharmaceuticals, Inc. (0001819790) (Filer)” looks
22 out of 100
“8-K/A - Tarsus Pharmaceuticals, Inc. (0001819790) (Filer)” scores 22 out of 100. The score uses 1 sources, a +1.04% difference versus the S&P 500 (SPY), and 2 linked companies.